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e a lt h c a r e s p e n d i n g i n t h e u n i t e d s tat e s grew 6.1 percent to $2.2 trillion, or $7,421 per person, in 2007 (Exhibits 1 and 2). The health spending share of gross domestic product (GDP) reached 16.2 percentan increase over the 16.0 percent share in 2006. This paper presents national health expenditure (NHE) estimates through 2007, with a focus on recent trends in the health care goods and services purchased, the sources of funds used to pay for those purchases, and the sponsors of U.S. health care spending. The NHE estimates measure the total annual spending for health care goods and services in the United States as well as spending for program administration; the net cost of private health insurance; government public health; and the amount invested in structures, equipment, and noncommercial research. These estimates are developed using data and information from a variety of sources such as Medicare and Medicaid program data, the Census Bureau's quinquennial Economic Census and Service Annual Survey, provider-based surveys, private health insurance filings with state insurance commissioners, and other sources. 1 The 2007 rate of growth in NHE was the slowest since 1998, and 0.6 of a per- 9 .0 percent to 6.9 percent, with slower growth in the net cost of private insurance and retail prescription drug spending as well as smaller slowdowns in several other categories such as hospital and government public health. From 2004 to 2007, NHE growth slowed much less rapidly, from 6.9 percent to 6.1 percent. While growth in prescription drug and physician and clinic spending contributed to the deceleration over the period, the relative stability of growth in hospital spending, which constituted just over 30 percent of total NHE, contributed to the moderation in the overall trend.
Between 2004 and 2007, public spending for health care grew at an average annual rate of 7.2 percent, compared with 5.9 percent for private spending. This recent spending trend is consistent with the longer-run experience, which shows an average annual growth of 10.5 percent for public spending and 9.5 percent for private spending between 1970 and 2004. As a result, the share of total NHE spending paid for by public sources increased from 37. Recent faster growth in public spending was attributable in part to healthrelated legislation, most notably the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003. Under this legislation, Medicare beneficiaries gained access to Part D prescription drug coverage in 2006, adding $40.5 billion to Medicare expenditures (this increase in public spending was partially offset by lower Medicaid drug spending for Medicare beneficiaries; Exhibit 3). Additionally, MMA authorized higher payments to Medicare Advantage (MA) plans, which created incentives for those plans to expand enrollment by increasing their areas of coverage and expanding the benefits offered. 3 Since the MA provisions of MMA were implemented in 2004, enrollment in MA plans has increased, on average, 17.0 percent annually. The main drivers of slower growth in private spending from 2004 to 2007 were slower growth in prescription drug spending and the net cost of private health insurance. Slower growth in retail prescription drug spending had a larger impact on private spending than on public spending, as private sources accounted for a majority (approximately two-thirds) of drug spending.
Retail Prescription Drugs
In 2007, retail prescription drug spending increased 4.9 percent to $227.5 billion; this was a deceleration from 8.6 percent growth in 2006. As mentioned ear-S p e n d i n g I n 2 0 0 7 lier, the factors that contributed to slower growth in 2007 included an increase in the generic dispensing rate, slower growth in prescription drug prices, and growing consumer safety concerns.
n Generic dispensing rate. The generic dispensing rate increased to 67 percent in 2007, up from 63 percent in 2006 and 60 percent in 2005. 4 Because generic drugs cost, on average, 30-80 percent less than brand-name drugs, increases in the generic dispensing rate contribute to slower spending growth. 5 The loss of patent exclusivity for several major blockbuster medications in 2006, including Flonase, Pravachol, Zocor, and Zoloft, had a large impact on the 2007 prescription drug trend, as sixmonth generic exclusivities expired for some of these drugs and additional generic medications became available. 6 Additionally, the impact of the loss of patent exclusivity for some major blockbusters in 2007, most notably Norvasc, Ambien, Lotrel, Coreg, and Toprol-XL, also contributed to increased use of generic drugs and slower 2 5 0 J a n u a r y / F e b r u a r y 2 0 0 9 D a t a W a t c h growth in total drug spending in 2007. 7 n Drug prices and growing safety concerns. Prescription drug prices, as reflected in the National Health Expenditure Accounts (NHEA), grew 1.4 percent in 2007, much slower than the 3.5 percent growth in 2006. 8 This lower price growth was driven in part by increased use of generics and the introduction of generic drug discount programs by large retail chain stores. 9 Increased safety concerns for certain prescription drugs in 2007 also likely influenced the drug spending trend, as the tors that may explain the slower per enrollee growth in Part D spending were (1) a reduction in plan bid levels, on average, as a result of the availability of later data on drug costs, as well as (2) plans' efforts to control costs by negotiating discounts and rebates with drug companies and (3) by monitoring utilization management. 13 Trends In Major Services n Hospitals. Hospital spending growth increased 7. Spending growth for MA is heavily influenced by increases or decreases in enrollment, as payments are based on plan-specific per member per month capitated
rates. Beginning in 2006, as mandated by MMA, payments are based on amounts "bid" by private MA plans. In addition, under MMA, payment rates to these plans were increased, which led to higher enrollment because plans could offer expanded coverage and provide additional benefits. 29 As such, per enrollee MA spending increased 15. The slowdown in total Medicare spending growth in 2007 was most dramatic for prescription drugs and administration. In addition, the slowdown was broadly 2 5 4 J a n u a r y / F e b r u a r y 2 0 0 9 . This acceleration was largely attributable to increases in inpatient and outpatient payments as states provided additional supplemental payments to hospitals. 31 Other personal health care and home health care also contributed to the increase in Medicaid spending in 2007, as states continued to use home and community-based services (HCBS) waivers and home health services as an alternative to institutional care. Medicaid spending for dental care (less than 2 percent of total Medicaid spending) increased 13.9 percent in 2007, a significant acceleration from growth of 2.7 percent in 2006. Recently, some states have taken steps to increase access to dental care by increasing provider payments and streamlining billing practices. Medicaid spending for other professional services also declined, falling 1.2 percent in 2007 after a decline of 0.6 percent in 2006. These types of services, which include providers such as podiatrists and chiropractors, are not mandatory in Medicaid and continue to be subject to state cuts and increases in copayments. 35 n Private health insurance spending. Private health insurance premiums increased 6.0 percent to $775.0 billion in 2007-the same rate as in 2006 but much lower than the recent peak of 10.7 percent in 2002. Some factors that explain the slower growth trend are a reduction in small employers' offer rates for insurance, a decline in the share of population covered by private insurance (from 68 percent in 2002 to 65 percent in 2007; data not shown), and the recent increased take-up rates of high-deductible plans (HDPs) and health savings accounts (HSAs). 36 The net cost of private health insurance (the difference between premiums and benefits) grew just 1.4 percent in 2007. Since 2004, spending for private health insurance premiums has grown at the same rate as or slower than spending for benefits, reducing the share of premiums accounted for by the net cost of private insurance from 13.2 percent in 2004 to 12.2 percent in 2007. Although more muted than in past decades, this trend is typical of a downturn in the underwriting cycle. 37 Private health insurance benefit payments accounted for 87.8 percent of premiums in 2007, and benefit growth slowed from a rate of 9.4 percent in 2002 to 6.6 percent in 2007. As noted earlier, an important factor was the slower growth in private health insurance payments for prescription drugs.
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In 2007, premiums for employment-based insurance continued to account for the vast majority (95 percent) of total private health insurance premiums. Employers' proportions of these premiums fell very slightly, from 73.1 percent in 2006 to 72.9 percent in 2007. The lower share in employer spending was due in part to the Medicare Part D retiree drug subsidy ($3.8 billion in 2006 and $4.0 billion in 2007), which is provided to employers that offer qualifying drug coverage to retired Medicare-eligible employees. This subsidy can be used to help offset the cost increases faced by both private businesses and state and local governments.
n Out-of-pocket spending. In 2007, out-of-pocket health spending grew 5.3 percent to $268.6 billion, after increasing 3.3 percent in 2006. This acceleration was mainly due to increased out-of-pocket spending for retail prescription drugs, nursing home services, and nondurable medical supplies. Out-of-pocket drug spending rebounded to a growth rate of 1.8 percent following a -4.0 percent decline in 2006 that was a result of the implementation of Medicare Part D, which shifted some outof-pocket spending for Medicare beneficiaries without drug coverage to Medicare Part D.
Analysis Of Spending By Sponsor
The relative shares of financing for the health services and supplies sponsored by businesses, households, government entities, and other private sources remained steady at both an aggregate and an underlying-detail level in 2007. 38 
Concluding Remarks
In 2007, health spending growth decelerated to 6.1 percent, the slowest rate since 1998, in part because of a forty-five-year low in the growth rate for prescription drug spending and slower growth in administrative spending associated with . Recent history has shown that through the downturns, health spending has remained somewhat insulated from the effects of a slowing economy and has increased as a share of GDP. With the uncertain economic climate and recent shifting of payment responsibilities in the health care system, the interaction between the economy and the share of it devoted to health spending will continue to be closely watched.
